scispace - formally typeset
Open AccessJournal ArticleDOI

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

TLDR
The revision clarifies the diagnosis and management of lesions at the very early stages of lymphomagenesis, refines the diagnostic criteria for some entities, details the expanding genetic/molecular landscape of numerous lymphoid neoplasms and their clinical correlates, and refers to investigations leading to more targeted therapeutic strategies.
About
This article is published in Blood.The article was published on 2016-05-19 and is currently open access. It has received 5321 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.

TL;DR: The further improvement in diagnostic methods and the further understanding of the pathogenesis of ocular adnexal EMZL may contribute to the establishment of a more successful multidisciplinary therapeutic planning.
Journal ArticleDOI

Systematic Review of the Potential of MicroRNAs in Diffuse Large B Cell Lymphoma.

TL;DR: The aim of this systematic review was to provide new insight into the role of miRNAs in the diagnosis, classification, treatment response and prognosis of DLBCL patients.
Journal ArticleDOI

Extranodal Marginal Zone Lymphoma of the Central Nervous System

TL;DR: CNS EMZBL is an indolent, low‐grade, radiosensitive lymphoma with good treatment outcomes and prognosis with an important differential to consider in extra‐axial dural‐based masses.
Journal ArticleDOI

EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management.

TL;DR: Epstein Barr virus‐positive (EBV+) diffuse large B‐cell lymphoma (DLBCL), not otherwise specified (NOS) is an entity included in the 2016 WHO classification of lymphoid neoplasms.
Journal ArticleDOI

Perspectives of bereaved relatives of patients with haematological malignancies concerning preferred place of care and death: A qualitative study.

TL;DR: Experiences and reflections of bereaved relatives of patients with leukaemia, lymphoma or myeloma are explored to examine preferred place of care and death; perceptions of factors influencing attainment of preferences; and changes that could promote achievement of preferences.
References
More filters
Book

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues

TL;DR: Thank you very much for reading who classification of tumours of haematopoietic and lymphoid tissues, and maybe you have knowledge that, people have look hundreds of times for their chosen readings like this, but end up in malicious downloads.
Journal ArticleDOI

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

TL;DR: The criteria and significance of early or precursor lesions and the identification of certain lymphoid neoplasms largely associated with particular age groups, such as children and the elderly are addressed, and the issue of borderline categories having overlapping features with large B-cell lymphomas is reviewed.
Journal ArticleDOI

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

TL;DR: The patterns of somatic mutation, supported by functional and clinical analyses, strongly indicate that the recurrent NOTCH1, MYD88 and XPO1 mutations are oncogenic changes that contribute to the clinical evolution of the disease.
Journal ArticleDOI

MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia

TL;DR: MYD88 L265P is a commonly recurring mutation in patients with Waldenström's macroglobulinemia that can be useful in differentiating WaldenStröm’s macrogalobulinesia and non-IgM LPL from B-cell disorders that have some of the same features.
Related Papers (5)